Orlistat
KGDobesity
Empros Pharma AB · Phase 2 · Status n/r · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Orlistat
Empros Pharma AB · Phase 2 · Status n/r · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.